Lv1
50 积分 2021-10-28 加入
Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy
11天前
已完结
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
28天前
已完结
A renaissance in targeting the PI3K/AKT/mTOR pathway
1个月前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
1个月前
已完结
A double‐blind, placebo‐controlled, single‐ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HM15136 , a novel long‐acting glucagon analogue, in healthy subjects
1个月前
已完结
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
1个月前
已完结
The evolving landscape of obesity pharmacotherapy
1个月前
已完结
Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis
1个月前
已完结
Insulin and glucagon signaling in the central nervous system
1个月前
已完结
Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor
1个月前
已完结
皖公网安备34019202002308
